Insider Trading Arrangements	3 Months Ended
Jun. 30, 2024 shares
Trading Arrangements, by Individual
Material Terms of Trading Arrangement	Rule 10b5-1 Trading Arrangements On May 15, 2024, J. Andy Corley, a member of our Board of Directors, entered into a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense conditions of Exchange Act Rule 10b5-1(c) (a “Rule 10b5-1 Trading Plan”) for the sale of securities of our common stock. Mr. Corley’s Rule 10b5-1 Trading Plan, which has a term from August 19, 2024 to May 20, 2025, provides for the sale of up to 40,000 shares of common stock at a pre-determined limit price. On May 21, 2024, Ron Kurtz M.D., Chief Executive Officer and President and a member of our Board of Directors, entered into a Rule 10b5-1 Trading Plan for the sale of securities of our common stock. Dr. Kurtz’s Rule 10b5-1 Trading Plan, which has a term from August 20, 2024 to August 15, 2025, provides for the sale of up to 180,000 shares of common stock pursuant to a series of market orders at pre-determined limit prices. On June 3, 2024, Ilya Goldshleger, Ph.D., Co-President and Chief Operating Officer, entered into a Rule 10b5-1 Trading Plan for the sale of securities of our common stock. Dr. Goldshleger’s Rule 10b5-1 Trading Plan, which has a term from September 16, 2024 to September 15, 2025, provides for the exercise and sale of options for up to 295,529 shares of common stock pursuant to a series of market orders at pre-determined limit prices. On June 7, 2024, Eric Weinberg., Co-President and Chief Commercial Officer, entered into a Rule 10b5-1 Trading Plan for the sale of securities of our common stock. Mr. Weinberg’s Rule 10b5-1 Trading Plan, which has a term from September 9, 2024 to September 9, 2025, provides for the sale of up to 100,000 shares of common stock pursuant to a series of market orders at pre-determined limit prices. On March 12, 2024, Julie Andrews, a member of our Board of Directors, entered into a Rule 10b5-1 Trading Plan for the sale of securities of our common stock. Ms. Andrews’ Rule 10b5-1 Trading Plan, which has a term from June 14, 2024 to March 20, 2025, provides for the sale of up to 15,625 shares of common stock at a pre-determined limit price.
J. Andy Corley [Member]
Trading Arrangements, by Individual
Name	J. Andy Corley
Title	Board of Directors
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	May 15, 2024
Arrangement Duration	274 days
Aggregate Available	40,000
Ron Kurtz M.D [Member]
Trading Arrangements, by Individual
Name	Ron Kurtz M.D
Title	Chief Executive Officer and President and a member of our Board of Directors
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	May 21, 2024
Arrangement Duration	360 days
Aggregate Available	180,000
Ilya Goldshleger [Member]
Trading Arrangements, by Individual
Name	Ilya Goldshleger
Title	Co-President and Chief Operating Officer
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	June 3, 2024
Arrangement Duration	364 days
Aggregate Available	295,529
Eric Weinberg [Member]
Trading Arrangements, by Individual
Name	Eric Weinberg
Title	Co-President and Chief Commercial Officer
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	June 7, 2024
Arrangement Duration	365 days
Aggregate Available	100,000
Julie Andrews [Member]
Trading Arrangements, by Individual
Name	Julie Andrews
Title	member of our Board of Directors
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	March 12, 2024
Arrangement Duration	279 days
Aggregate Available	15,625

Insider Trading Arrangements

3 Months Ended

Jun. 30, 2024

Rule 10b5-1 Trading Arrangements

On May 15, 2024, J. Andy Corley, a member of our Board of Directors, entered into a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense conditions of Exchange Act Rule 10b5-1(c) (a “Rule 10b5-1 Trading Plan”) for the sale of securities of our common stock. Mr. Corley’s Rule 10b5-1 Trading Plan, which has a term from August 19, 2024 to May 20, 2025, provides for the sale of up to 40,000 shares of common stock at a pre-determined limit price.

On May 21, 2024, Ron Kurtz M.D., Chief Executive Officer and President and a member of our Board of Directors, entered into a Rule 10b5-1 Trading Plan for the sale of securities of our common stock. Dr. Kurtz’s Rule 10b5-1 Trading Plan, which has a term from August 20, 2024 to August 15, 2025, provides for the sale of up to 180,000 shares of common stock pursuant to a series of market orders at pre-determined limit prices.

On June 3, 2024, Ilya Goldshleger, Ph.D., Co-President and Chief Operating Officer, entered into a Rule 10b5-1 Trading Plan for the sale of securities of our common stock. Dr. Goldshleger’s Rule 10b5-1 Trading Plan, which has a term from September 16, 2024 to September 15, 2025, provides for the exercise and sale of options for up to 295,529 shares of common stock pursuant to a series of market orders at pre-determined limit prices.

On June 7, 2024, Eric Weinberg., Co-President and Chief Commercial Officer, entered into a Rule 10b5-1 Trading Plan for the sale of securities of our common stock. Mr. Weinberg’s Rule 10b5-1 Trading Plan, which has a term from September 9, 2024 to September 9, 2025, provides for the sale of up to 100,000 shares of common stock pursuant to a series of market orders at pre-determined limit prices.

On March 12, 2024, Julie Andrews, a member of our Board of Directors, entered into a Rule 10b5-1 Trading Plan for the sale of securities of our common stock. Ms. Andrews’ Rule 10b5-1 Trading Plan, which has a term from June 14, 2024 to March 20, 2025, provides for the sale of up to 15,625 shares of common stock at a pre-determined limit price.

J. Andy Corley [Member]

Trading Arrangements, by Individual

Name

J. Andy Corley

Title

Board of Directors

Rule 10b5-1 Arrangement Adopted

true

Adoption Date

May 15, 2024

Arrangement Duration

274 days